Background: HLA-G is a nonclassical, class I major histocompatibility complex (MHC) gene 25
Introduction 50
Maternal and fetal immune cells are in close contact during pregnancy, with apparent tolerance 51 of maternal cells toward the fetus and vice versa. It has been suggested that HLA-G is an 52 immunomodulatory molecule that contributes toward this tolerance, although the precise 53 mechanisms are not completely known (Carosella et al., 2008; Hunt et al., 2005; Hviid, 2006) . 54 HLA-G is considered a "non-classical" class I HLA due to its limited coding region 55 polymorphism and restricted tissue distribution compared to classical class I HLA (HLA-A, HLA-56 B, HLA-C). Moreover, HLA-G transcripts have the unique property among HLA genes in that 57 they undergo alternative splicing to generate at least seven transcripts and four protein isoforms 58 To date, however, interrogation of multiple HLA-G polymorphisms, sHLA-G 71 concentrations, and clinical outcomes has not been considered in the same study population. In 72 addition, nearly all studies of HLA-G and clinical outcomes have focused on women of 73 European or European American descent, even though the frequencies of HLA-G polymorphisms 74 differ considerably between racial and ethnic groups and minor allele frequencies for some 75 variants are too rare in European populations to assess their effects on sHLA-G levels or 76 pregnancy outcome. Therefore, comprehensive studies of HLA-G genotypes, sHLA-G levels, and 77 clinical outcomes in ethnically diverse populations are required to assess the functional or 78 clinical effects of all HLA-G variants. 79
To address these gaps and to comprehensively survey the effects of genetic variation in 80 HLA-G on both circulating levels of sHLA-G in the first trimester of pregnancy and RPL, we 81 initiated studies in women from the Basrah Province of Iraq, a population that has not previously 82 been studied for RPL, HLA-G polymorphisms, and sHLA-G concentrations. 
Sample Composition 86
Women (N=50) classified as having recurrent pregnancy loss (RPL), defined by two or more 87 consecutive miscarriages of less than 20 weeks gestation and a negative RLP evaluation, were 88 recruited from the Obstetrics Unit at the Basrah Maternity and Childrens Hospital when they 89 presented to Emergency with a miscarriage that became symptomatic between 9 and 12 weeks 90 gestation. On evaluation, these women had normal levels of serum progesterone levels (>10 91 ng/mol) and normal thyroid function (T3 between 0.9-2.5 mIU/ml; T4 between 60-120 mIU/ml); 92 antiphospholipid antibodies, anticardiolipin antibodies, antinuclear antibodies, and TORCH 93 (toxoplasmosis, rubella, cytomegalovirus, herpes simplex virus) studies were negative. These 94 women were treated with either low dose aspirin or progesterone during the index pregnancy. 95
Control women (N=50) were healthy pregnant women, recruited between 9 and 12 weeks 96 gestation from the same hospital as the women with RPL, and who delivered the index 97 pregnancy at term. Controls had at least one child and no previous miscarriages, preterm 98 deliveries, or stillbirths. 99
Three milliliters of EDTA-anticoagulated venous blood was collected from each woman 100 with RPL prior to the infusion of intravenous fluids and from each control woman. Plasma was 101 removed following centrifugation for 5 minutes at 3000 rpm and frozen in 100 µL aliquots. DNA 102 was extracted from the remaining cells, using the phenol-chloriform extraction protocol of 103 Sambrook et al. (Sambrook et al., 1989) , and stored frozen. Frozen plasma and DNA were 104 shipped on dry ice from Basrah, Iraq to Chicago for genotyping and sHLA-G studies. 
HLA Genotyping 109
DNA samples were genotyped for six polymorphisms ( that disrupts a micro(mi)RNA target site and influences HLA-G expression levels in the presence 123 of the miRNAs (Tan et al., 2007) . 124
These six variants define the following eight HLA-G alleles (referred to here as 125 haplotypes) (Table I) case, two controls), the genotypes at the six polymorphic sites were not consistent with two 132 known haplotypes, representing either genotyping error or identification of previously 133 unreported haplotypes. Because of limited DNA availability we could not differentiate between 134 these two possibilities, and these samples were excluded from analyses of haplotypes. 135
Measurements of sHLA-G Concentrations 136
sHLA-G ELISA kits were purchased from EXBIO (Vestec, Czech Republic)/BioVendor (Brno, 137
Czech Republic) for measurement of soluble G5 and shed transmembrane G1 in plasma samples, 138 according to the manufacturer's instructions. All samples were run in duplicate; and mean 139 absorbances, measured at a wavelength of 450 nm, were determined for each subject. Calibration 140 curves based on the absorbance of calibrators of known concentration were used to determine the 141 concentration of sHLA-G in each sample. 142
Statistical Analyses 143
Frequencies of alleles at each of the six variants and for each of the eight haplotypes were 144 compared between RPL cases and healthy controls by the Pearson χ 2 test, or a Fisher exact test if 145 cell counts were <5. Associations between individual polymorphisms or haplotypes and sHLA-G 146 levels were evaluated by nonparametric methods, using either the Wilcoxon rank sum test (to 147 compare 2 groups) or the Kruskal-Wallis test (to compare 3 or more groups). The effective 148 number of independent tests performed in the analysis of genetic associations with sHLA-G was 149 estimated given the correlation structure among polymorphisms using Li and Ji's method (2005) , 150 as implemented in the matrix spectral decomposition (matSpD) program (Nyholt, 2004) 
. Li and 151
Ji's method indicated that the six polymorphisms in HLA-G represented 5.19 independent 152 variables. Significant P-values from the tests of genetic associations were therefore corrected for 153 5.19 tests using the Bonferroni correction and are presented as P corrected . Linear regression was 154 used to test for an association between log sHLA-G concentration and maternal age, and the 155 direction and strength of this association was estimated using the Pearson product-moment 156 correlation coefficient (r). Multivariate analysis of the combined effect of maternal age, -725 157 genotype, and RPL status on sHLA-G levels was performed on log-transformed sHLA-G 158 measurements using a standard least squares regression. Analyses were performed using JMP 159 software (SAS Institute Inc., Cary, NC), version 8.0.2.2. P-values < 0.05 were considered 160 significant. 161
Results 162
The RPL cases and healthy controls included in this study are described in Table II . Cases had 163 significantly more pregnancies on average compared to the control women (mean 4.3 vs. 3.4, 164 respectively), whereas control women had significantly more live born children on average 165 compared to the RPL cases (mean 2.4 vs. 0.42, respectively). Circulating levels of sHLA-G in 166 the first trimester were significantly lower in RPL cases compared to controls (median 167 concentration = 21.3 U/ml and 38.8 U/ml, respectively; Wilcoxon rank sum test, P = 0.025) (Fig.  168   2) . Log sHLA-G concentration was also significantly negatively correlated with maternal age (F 169 ratio = 8.2, r = -0.28, P = 0.0051) (Supplementary data, Fig. S1 ), but not with number of prior 170 pregnancies or live births (P > 0.50; data not shown). 171
We were able to successfully genotype 49 RPL cases and 48 controls. The genotype 172 counts at each of the six variants were in Hardy-Weinberg equilibrium in cases only, in controls 173 only, and in the combined sample (data not shown). The frequencies of alleles at each 174 polymorphic site in the cases and controls are shown in Table III . None of the allele frequencies 175
were significantly different between the two groups, although there was a trend toward a higher 176 frequency of the insertion allele at the 14bp indel in the cases compared to controls (0.62 vs. 177 0.51; P = 0.12). 178
The frequencies of each of the eight haplotypes in cases, controls and the combined 179 sample of Iraqi women are shown in Table IV . Overall, the G*010101 and G*010102 haplotypes 180 were the most common haplotypes, similar to other populations. However, all other haplotypes 181 were relatively more frequent in the Iraqi women compared to many other populations (Hviid, also among the highest ever reported (Hviid, 2006) . Nonetheless, haplotype frequencies did not 187 significantly differ between cases and controls; although the relatively rare G*010103 haplotype 188 occurred in six cases and only one control (P = 0.12) and the G*0104 haplotype was relatively 189 more common in controls compared to cases (P = 0.12). 190
We next examined associations between HLA-G genotype and sHLA-G concentrations 191 (Table V) . Only one polymorphism, -725C/G/T, was significantly associated with sHLA-G 192 levels in the combined sample (Kruskal-Wallis test; P = 0.0089); this association remained 193 significant after Bonferroni correction (P corrected = 0.046) (Fig. 3) . The concentration of sHLA-G 194 was lowest among women with the common CC genotype (median = 21.1 U/ml) compared to 195 women with the CG (median = 40.1 U/ml) and CT (median 42.6 U/ml) genotypes (no women 196 were homozygous for the G or T alleles). This pattern of association was similar in both the RPL 197 cases and healthy controls. were significantly associated with log sHLA-G concentration, while the effect of case/control 202 status approached statistical significant (P = 0.056). The multivariate model that included all 203 three of these predictor variables was highly significant (F ratio = 7.57, P-value = 1.37x10 -4 ), 204 explaining 19.6% of the variance in log sHLA-G levels. Notably, both genotype and maternal 205 age effects on log sHLA-G concentration remained significant in the multivariate model (P = 206 0.012 and P = 0.0017, respectively), whereas the effect of RPL status on log sHLA-G levels 207 failed to achieve statistical significance (P = 0.066) when -725 genotype and maternal age are 208 included in the model. In the multivariate model, maternal age and -725 genotype account for 209 5.7% and 9.0%, respectively, of the total variance in log sHLA-G concentration. Overall, these 210 results indicate that HLA-G genotype and maternal age independently influence circulating 211 concentrations of sHLA-G during the first trimester of pregnancy in Iraqi women. 
Discussion 213
We present here the first study of HLA-G in Iraqi women and examine the effects of genotypes 214 on RPL and circulating levels of sHLA-G. We report a significant association between an HLA-215 G promoter polymorphism, -725C/G/T, and sHLA-G concentrations in the first trimester of 216 pregnancy in women with RPL and in healthy controls. We show, in addition, that sHLA-G 217 concentrations significantly decrease with increasing maternal age. Perhaps not surprisingly, 218 sHLA-G concentrations were lower in women experiencing a miscarriage. However, because -219 725C/G/T genotype frequencies did not differ between RPL cases and healthy controls and the 220 effect of pregnancy status (RPL case versus control) was reduced when genotype and maternal 221 age were included in a multivariate model, we suggest that reduced concentrations of circulating 222 sHLA-G in the RPL cases resulted from the miscarriage but were not causing the pregnancy loss. 223
There have been few studies of the HLA-G -725C/G/T polymorphism, but as part of a 224 comprehensive study of variation in the promoter region of HLA-G, we previously reported an 225 association between the -725G allele and sporadic miscarriage in fertile couples (the -725T allele 226
was not surveyed at that time) (Ober et al., 2003) . We subsequently demonstrated that the G 227 allele was associated with increased HLA-G expression in a reporter assay (Ober et al., 2006) , 228 consistent with the findings in the current study (Fig. 3) . In our earlier study, we reported that 229 Given the high frequency of the 1597∆C allele in Iraqi women, it was unexpected that 256 this allele was not associated with sHLA-G concentrations because it is a proven null allele for 257 the G1 and G5 isoforms (Ober et al., 1998) , which are the two isoforms measured by the ELISA 258 Americans (Tan et al., 2005) , and 0.12 in Iraqi women. In contrast, the -725G allele occurs at 274 frequencies of 0.12 in European Americans and 0.068 in African Americans (Tan et al., 2005) , 275 and 0.11 in Iraqi women. As a result, the -725 CC genotype is less common in Iraqi women 276 compared to either European American or African American subjects. 277
This study provides novel insights into the regulation of circulating levels of sHLA-G in 278 early pregnancy and clinical outcome. First, the lack of an association between the -725 CC 279 genotype and RPL, despite the observation of significantly lower sHLA-G concentrations in CC 280 women, suggests that constitutively low levels of sHLA-G due to -725 genotype is not a cause of 281 recurrent pregnancy loss in these women. This would be consistent with the observation that CC 282 is the most common genotype at this site, and indicates that the genotype-specific differences 283 observed in this study are likely well within the range required for successful implantation and 284 maintenance of pregnancy. Interestingly, even at 9-12 weeks of gestation in spontaneously 285 terminating pregnancies, the genotype effects on sHLA-G concentrations are still apparent. 286
Whether these genotype effects on sHLA-G concentrations remain throughout pregnancy, or 287 whether they predict outcomes later in pregnancy remains to be determined. Second, we report 288 an unexpected association between sHLA-G concentrations and maternal age that is independent 289 of the HLA-G genotype effect. This observation needs to be replicated in additional studies, and 290 Table I . Associations between six genotyped variants and eight imputed HLA-G haplotypes. 468
ncludes the 010101, 010104, and 010108 haplotypes that cannot be differentiated by these six polymorphisms. 
